Literature DB >> 35471686

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone.

Chongsheng Cheng1, Yani Wang1, Danjing Hu1, Wangji Zhou1, Chunlong Liu2, Xinlun Tian1, Hongbing Zhang3, Ying-Chun Xu4, Kai-Feng Xu5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35471686      PMCID： PMC9039973          DOI： 10.1007/s11427-022-2102-3

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   10.372


× No keyword cloud information.
  9 in total

1.  European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.

Authors:  S R Johnson; J F Cordier; R Lazor; V Cottin; U Costabel; S Harari; M Reynaud-Gaubert; A Boehler; M Brauner; H Popper; F Bonetti; C Kingswood
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

Review 2.  The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis.

Authors:  Andrew M Courtwright; Hilary J Goldberg; Elizabeth Petri Henske; Souheil El-Chemaly
Journal:  Eur Respir Rev       Date:  2017-01-17

3.  Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Authors:  Francis X McCormack; Yoshikazu Inoue; Joel Moss; Lianne G Singer; Charlie Strange; Koh Nakata; Alan F Barker; Jeffrey T Chapman; Mark L Brantly; James M Stocks; Kevin K Brown; Joseph P Lynch; Hilary J Goldberg; Lisa R Young; Brent W Kinder; Gregory P Downey; Eugene J Sullivan; Thomas V Colby; Roy T McKay; Marsha M Cohen; Leslie Korbee; Angelo M Taveira-DaSilva; Hye-Seung Lee; Jeffrey P Krischer; Bruce C Trapnell
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

4.  mTOR inhibition improves immune function in the elderly.

Authors:  Joan B Mannick; Giuseppe Del Giudice; Maria Lattanzi; Nicholas M Valiante; Jens Praestgaard; Baisong Huang; Michael A Lonetto; Holden T Maecker; John Kovarik; Simon Carson; David J Glass; Lloyd B Klickstein
Journal:  Sci Transl Med       Date:  2014-12-24       Impact factor: 17.956

5.  TORC1 inhibition enhances immune function and reduces infections in the elderly.

Authors:  Joan B Mannick; Melody Morris; Hans-Ulrich P Hockey; Guglielmo Roma; Martin Beibel; Kenneth Kulmatycki; Mollie Watkins; Tea Shavlakadze; Weihua Zhou; Dean Quinn; David J Glass; Lloyd B Klickstein
Journal:  Sci Transl Med       Date:  2018-07-11       Impact factor: 17.956

6.  Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline.

Authors:  Nishant Gupta; Geraldine A Finlay; Robert M Kotloff; Charlie Strange; Kevin C Wilson; Lisa R Young; Angelo M Taveira-DaSilva; Simon R Johnson; Vincent Cottin; Steven A Sahn; Jay H Ryu; Kuniaki Seyama; Yoshikazu Inoue; Gregory P Downey; MeiLan K Han; Thomas V Colby; Kathryn A Wikenheiser-Brokamp; Cristopher A Meyer; Karen Smith; Joel Moss; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

7.  Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.

Authors:  Danuta M Skowronski; Yossi Febriani; Manale Ouakki; Solmaz Setayeshgar; Shiraz El Adam; Macy Zou; Denis Talbot; Natalie Prystajecky; John R Tyson; Rodica Gilca; Nicholas Brousseau; Geneviève Deceuninck; Eleni Galanis; Chris D Fjell; Hind Sbihi; Elise Fortin; Sapha Barkati; Chantal Sauvageau; Monika Naus; David M Patrick; Bonnie Henry; Linda M N Hoang; Philippe De Wals; Christophe Garenc; Alex Carignan; Mélanie Drolet; Agatha N Jassem; Manish Sadarangani; Marc Brisson; Mel Krajden; Gaston De Serres
Journal:  Clin Infect Dis       Date:  2022-04-19       Impact factor: 9.079

8.  The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.

Authors:  Rachael Keating; Tomer Hertz; Marie Wehenkel; Tarsha L Harris; Benjamin A Edwards; Jennifer L McClaren; Scott A Brown; Sherri Surman; Zachary S Wilson; Philip Bradley; Julia Hurwitz; Hongbo Chi; Peter C Doherty; Paul G Thomas; Maureen A McGargill
Journal:  Nat Immunol       Date:  2013-10-20       Impact factor: 25.606

9.  Poor Antibody Response After Two Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in Transplant Recipients.

Authors:  Alessandra Mazzola; Eve Todesco; Sarah Drouin; Fanny Hazan; Stéphane Marot; Dominique Thabut; Shaida Varnous; Cathia Soulié; Benoît Barrou; Anne-Geneviève Marcelin; Filomena Conti
Journal:  Clin Infect Dis       Date:  2022-03-23       Impact factor: 9.079
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.